This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Investival Europe
Life Science Fundraising & Investment
7-8 April 2027 - Main days, Lyon, France6 April 2027 - Pre-day forums (Life Science Companies only)
Menu

Biotech Insights Unlocked: Expert Talks on Investment, Deals & Growth

Stay ahead in the biotech industry with exclusive interviews, expert guest opinions, and strategic insights on biotech investment, valuation, venture capital, partnering, licensing, and commercialisation. Gain the knowledge and connections you need to accelerate growth and make informed business decisions.

The LSX Investival Europe is where the global biotech community comes together to address the most pressing challenges facing the sector today, from tightening capital markets and rising development risk, to translating early innovation and unlocking sustainable commercial value.

From early discovery to scale-up and global expansion, the Congress facilitates the conversations, connections, and insights that turn ambition into progress.

LSX Investival Europe offers a unique opportunity to align science, strategy, and capital in one global forum.

Capital Markets & Investment Strategies

  • How capital flows are shifting across private, public, and alternative markets
  • What investors now prioritise when evaluating opportunities
  • How companies can align financing strategies with long-term growth and exit goals
  • The impact of regional, geopolitical, and macroeconomic factors on investment
Learn more about investment strategies

Early Innovation & Technology Translation

  • Translating academic and early-stage research into viable commercial ventures
  • Identifying the right development pathways and indications early on
  • Building teams, partnerships, and IP strategies that attract capital
  • Reducing technical and clinical risk while preserving long-term value
Dive into early innovation technology

Market Opportunities & Commercialisation

  • Identifying high-growth therapeutic and technology markets
  • Aligning innovation with real-world healthcare needs
  • Integrating AI, data, and digital tools into commercial strategy
  • Planning market access, pricing, and reimbursement earlier in development
What market opportunities could you discover?

Meet the CEOs

Meet the CEOs shaping biotech’s future. In this series, industry leaders share their visions, strategies, and insights on innovation, investment, and growth.

Sana Alajmovic: Pioneering Innovation in Metabolic Health

Read Here

Jenny Barnett: Spearheading Precision Medicine in Neuroscience

Read Here

Colleen Acosta: How Freya Biosciences is Transforming Women's Reproductive Health

Read Here

Join the Community

Follow us on LinkedIn for exclusive insights into event content, daily updates on the latest happenings, and more.

Don’t miss a moment—join the conversation today!

Join Our Community

FAQs

expand_less

Who should attend the Biotech Leaders track?

The track is designed for senior executives and decision makers in the biotech/life sciences ecosystem – including founders and CEOs of biotech companies, investors (VCs, crossover funds, corporate venture), tech transfer professionals from academia, and service providers supporting biotech innovation.